- Home
- WWW vs MDXG Comparison
WWW vs MDXG Comparison
Compare WWW & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WWW
- MDXG
- Stock Information
- Founded
- WWW 1883
- MDXG 2006
- Country
- WWW United States
- MDXG United States
- Employees
- WWW N/A
- MDXG N/A
- Industry
- WWW Shoe Manufacturing
- MDXG Biotechnology: Pharmaceutical Preparations
- Sector
- WWW Consumer Discretionary
- MDXG Health Care
- Exchange
- WWW Nasdaq
- MDXG Nasdaq
- Market Cap
- WWW 1.0B
- MDXG 877.4M
- IPO Year
- WWW N/A
- MDXG N/A
- Fundamental
- Price
- WWW $23.24
- MDXG $6.77
- Analyst Decision
- WWW Buy
- MDXG Strong Buy
- Analyst Count
- WWW 6
- MDXG 2
- Target Price
- WWW $19.33
- MDXG $11.50
- AVG Volume (30 Days)
- WWW 1.4M
- MDXG 943.2K
- Earning Date
- WWW 08-06-2025
- MDXG 07-30-2025
- Dividend Yield
- WWW 1.71%
- MDXG N/A
- EPS Growth
- WWW N/A
- MDXG N/A
- EPS
- WWW 0.90
- MDXG 0.27
- Revenue
- WWW $1,772,400,000.00
- MDXG $352,375,000.00
- Revenue This Year
- WWW $4.96
- MDXG $9.55
- Revenue Next Year
- WWW $5.48
- MDXG $11.43
- P/E Ratio
- WWW $26.13
- MDXG $24.29
- Revenue Growth
- WWW N/A
- MDXG 5.34
- 52 Week Low
- WWW $9.58
- MDXG $5.47
- 52 Week High
- WWW $24.64
- MDXG $10.14
- Technical
- Relative Strength Index (RSI)
- WWW 77.56
- MDXG 54.91
- Support Level
- WWW $18.87
- MDXG $6.37
- Resistance Level
- WWW $19.93
- MDXG $6.99
- Average True Range (ATR)
- WWW 0.75
- MDXG 0.33
- MACD
- WWW 0.33
- MDXG 0.03
- Stochastic Oscillator
- WWW 90.10
- MDXG 73.33
About WWW Wolverine World Wide Inc.
Wolverine World Wide Inc is engaged in designing, manufacturing, sourcing, marketing, licensing, and distributing branded footwear, apparel, and accessories. The company's segment includes Active Group; Work Group; Corporate and Other. It generates maximum revenue from the Active Group segment. Active Group segment consists of Merrell footwear and apparel, Saucony footwear and apparel, Sweaty Betty activewear, and Chaco footwear.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.